Anti-Heart Failure Drug -- rhNRG-1 has Complete Chinese Phase II Clinical Trials

Zensun has competed Chinese Phase II Clinical Trials of its innovative anti-heart failure drug — rhNRG-1. Part of results were published in JACC. Our outcomes have been specially reported by Reuters' the Doctor Channel. http://www.thedoctorschannel.com/video/3204.html

The release as fetched from its publisher. zensun.com ↗